Clinical trial shows fecal microbiota transplantation could help patients heal after stem cell transplantation

A new study shows that oral fecal microbiota transplantation (FMT) is a feasible and safe addition to preventing graft-versus-host disease in patients undergoing stem cell transplantation for blood cancers.

Leave A Comment

Your email address will not be published. Required fields are marked *